Recapture of patients with an incomplete diagnosis of hepatitis C virus infection

被引:5
|
作者
Burgui, Cristina [1 ,2 ,3 ]
Martin, Carmen [3 ,4 ]
Juanbeltz, Regina [2 ,3 ,5 ]
San Miguel, Ramon [3 ,5 ]
Martinez-Baz, Ivan [1 ,2 ,3 ]
Manuel Zozaya, Jose [3 ,6 ]
Castilla, Jesus [1 ,2 ,3 ]
机构
[1] Inst Salud Publ Navarra, C Leyre 15, Navarra 31003, Spain
[2] CIBER Epidemiol & Salud Publ CIBERESP, Navarra, Spain
[3] Inst Invest Sanitaria Navarra IdiSNA, Navarra, Spain
[4] Complejo Hosp Navarra, Dept Clin Microbiol, Navarra, Spain
[5] Complejo Hosp Navarra, Dept Pharm, Navarra, Spain
[6] Complejo Hosp Navarra, Dept Digest Dis, Navarra, Spain
关键词
Hepatitis C virus; Direct-acting antivirals; Sustained virological response; Eradication strategy; Undiagnosed infection; DIRECT-ACTING ANTIVIRALS; GENOTYPE; BOCEPREVIR; RIBAVIRIN; THERAPY;
D O I
10.17235/reed.2020.6944/2020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: hepatitis C virus (HCV) antibody tests have been performed since the 90s, although HCV-RNA (viral load) determination was not always performed. Some of these patients may be actively infected and not be aware of it. Here, we describe a procedure to capture these subjects and complete their diagnosis. Methods: the historical laboratory results of Navarra were reviewed and individuals who were positive for antibodies against HCV (anti-HCV) and had not undergone HCV-RNA testing were identified. In September 2018, each general practitioner (GP) was informed about their patients and given precise instructions for completing the diagnosis. The procedure was assessed until December 2019. Results: two hundred and eighty-nine anti-HCV positive patients were detected for whom active infection had not been discarded. Two were HIV-positive and six had already died. GPs were asked to assess the remaining 281 subjects. By the end of 2019, a new blood test had been performed in 187 (67 %) patients, 5 % decided not to do it, 4 % were living outside of Navarra, 3 % could not be contacted and the GP considered that it was not justified in 2 % of cases. Thus, 19 % remained to be contacted. From the 187 assessed patients, active infection was confirmed in 52 (28%) individuals, 40 % were false positives and HCV-RNA was undetectable in 31 %. Regarding the 52 actively infected subjects, 34 had already initiated antiviral therapy and three were hospitalized due to decompensated cirrhosis, from which one patient died. Conclusions: the strategy to recapture individuals with an incomplete HCV infection diagnosis was effective to detect active infections and subsequent initiation of antiviral therapy.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 50 条
  • [1] Vedroprevir in the management of hepatitis C virus infection
    Abutaleb, Ameer
    Kottilil, Shyamasundaran
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (12) : 1399 - 1402
  • [2] Daclatasvir for the treatment of hepatitis C virus infection
    Adler, Hugh
    Lambert, John S.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 725 - 738
  • [3] Revolution in the diagnosis and management of hepatitis C virus infection in current era
    Hanif, Farina M.
    Majid, Zain
    Luck, Nasir Hassan
    Tasneem, Abbas Ali
    Laeeq, Syed Muddasir
    Mubarak, Muhammed
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (04) : 647 - U24
  • [4] The Burden of Untreated Hepatitis C Virus Infection: A US Patients' Perspective
    El Khoury, Antoine C.
    Vietri, Jeffrey
    Prajapati, Girish
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (11) : 2995 - 3003
  • [5] Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection
    Papudesu, Chandana
    Kottilil, Shyamasundaran
    Bagchi, Shashwatee
    HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 152 - 160
  • [6] A new era of therapy for hepatitis C virus infection
    Nyalakonda, Harita
    Utay, Netanya S.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (05) : 471 - 478
  • [7] Hepatitis C virus infection and hepatocarcinogenesis
    Berta Evelin
    Egresi Anna
    Bacsardi Anna
    Gaspar Zsofia
    Lengyel Gabriella
    Hagymasi Krisztina
    ORVOSI HETILAP, 2019, 160 (22) : 846 - 853
  • [8] Telaprevir for Chronic Hepatitis C Virus Infection
    Jesudian, Arun B.
    Jacobson, Ira M.
    CLINICS IN LIVER DISEASE, 2013, 17 (01) : 47 - +
  • [9] Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virus
    Perez-Garcia, Alejandra
    Aguinaga, Aitziber
    Navascues, Ana
    Castilla, Jesus
    Ezpeleta, Carmen
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2019, 89 : 131 - 136
  • [10] Noninvasive Diagnosis of Hepatic Fibrosis in Hemodialysis Patients with Hepatitis C Virus Infection
    Liu, Chen-Hua
    Kao, Jia-Horng
    DIAGNOSTICS, 2022, 12 (10)